Which peptides are best for mitochondria
doi:10.1053/j.gastro.2014.09.016 53
Mean weight reductions were 16.0%, 21.4%, and 22.5% at the 5, 10, and 15 mg doses respectively, versus about 2.4% with placebo, with the majority of participants at the top doses losing at least 20% of body weight
A Phase III, Randomised, Double Blind, Placebo Controlled, Parallel Group Study, to Evaluate the Safety and Efficacy of Subcutaneous Implants of Afamelanotide (16 mg) in Patients Suffering From Polymorphic Light Eruption (PLE) (Report)
Check metabolic markers throughout treatment
together, these compounds form a reversible oxidation-reduction system